Prospective Assessment of Biomarkers of Hypercoagulability in Oncological Patients and Healthcare Workers Following Vaccination Against Sars-Cov-2 with the mRNA Vaccine. the Roadmap-COVID-19-Vaccin Study

Background: COVID-19 has been associated with hypercoagulability, endothelial cell injury and frequent thrombotic complications resulting both from direct effects of the virus on the endothelium and from the ‘cytokine storm’ resulting from the host's immune response. Since the COVID-19 vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Dreden, Patrick, Gligorov, Joseph, Terpos, Evangelos, Jamelot, Mathieu, Sabbah, Michele, Fotiou, Despina, Ka, Aboubakr, Charitaki, Joanna, Elalamy, Ismail, Bagratuni, Tina, Fareed, Jawed, Rousseau, Aurélie, Dimopoulos, Meletios A., Gerotziafas, Grigoris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
331.Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701536/
http://dx.doi.org/10.1182/blood-2021-146803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701536/
http://dx.doi.org/10.1182/blood-2021-146803

Ejemplares similares